Annual Report And Accounts

Overview

The report describes a year of resilient performance for the company, with Group revenue of £9.2 million despite COVID-19 disruption and a major client trial descope. It highlights over £1.8 million invested in the next-generation TrialTracker platform and continued development of AI-enabled neurological imaging analytics. The company also moved to fully remote working during the pandemic and introduced a hybrid working model to support employees and reduce travel impacts.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: Ends 30 September 2021
Publication date: 6 December 2021
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services